Alector Inc.

13.20+0.5400+4.27%Vol 889.62K1Y Perf -54.64%
Aug 12th, 2022 16:00 DELAYED
BID8.00 ASK14.99
Open12.85 Previous Close12.66
Pre-Market- After-Market12.80
 - -  -0.40 -3.03%
Target Price
20.75 
Analyst Rating
Moderate Buy 1.72
Potential %
57.20 
Finscreener Ranking
★★★★     53.78
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★+     54.53
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★+     65.90
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
26.15 
Earnings Rating
Strong Sell
Market Cap1.09B 
Earnings Date
2nd Aug 2022
Alpha-0.01 Standard Deviation0.19
Beta1.13 

Today's Price Range

12.840.00

52W Range

7.5029.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
1.07%
1 Month
13.50%
3 Months
53.13%
6 Months
-18.97%
1 Year
-54.64%
3 Years
-25.84%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ALEC13.200.54004.27
AAPL172.123.63002.15
GOOG122.652.83002.36
MSFT291.914.89001.70
XOM94.000.81000.87
WFC45.940.69001.52
JNJ165.30-1.8400-1.10
FB196.640.99000.51
GE79.931.03001.31
JPM122.131.99001.66
 
ProfitabilityValueIndustryS&P 500US Markets
-
12.00
14.80
-570.80
12.06
RevenueValueIndustryS&P 500US Markets
300.73M
3.64
93.64
137.20
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.390.12130.77
Q01 20220.37-0.54-245.95
Q04 2021-0.13-0.68-423.08
Q03 20212.981.49-50.00
Q02 2021-0.69-0.690.00
Q01 2021-0.68-0.662.94
Q04 2020-0.61-0.66-8.20
Q03 2020-0.54-0.67-24.07
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.39-39.29Negative
9/2022 QR-0.2513.79Positive
12/2022 FY-1.36-142.86Negative
12/2023 FY-0.95-18.75Negative
Next Report Date-
Estimated EPS Next Report-0.39
Estimates Count6
EPS Growth Next 5 Years %45.40
Volume Overview
Volume889.62K
Shares Outstanding82.56K
Shares Float61.65M
Trades Count8.82K
Dollar Volume11.66M
Avg. Volume543.72K
Avg. Weekly Volume604.22K
Avg. Monthly Volume453.16K
Avg. Quarterly Volume573.77K

Alector Inc. (NASDAQ: ALEC) stock closed at 13.2 per share at the end of the most recent trading day (a 4.27% change compared to the prior day closing price) with a volume of 889.62K shares and market capitalization of 1.09B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 171 people. Alector Inc. CEO is Arnon Rosenthal.

The one-year performance of Alector Inc. stock is -54.64%, while year-to-date (YTD) performance is -36.08%. ALEC stock has a five-year performance of %. Its 52-week range is between 7.5 and 29.3, which gives ALEC stock a 52-week price range ratio of 26.15%

Alector Inc. currently has a PE ratio of 32.50, a price-to-book (PB) ratio of 3.62, a price-to-sale (PS) ratio of 3.48, a price to cashflow ratio of 2.20, a PEG ratio of 2.32, a ROA of 5.63%, a ROC of 12.76% and a ROE of 15.33%. The company’s profit margin is 12.06%, its EBITDA margin is 14.80%, and its revenue ttm is $300.73 Million , which makes it $3.64 revenue per share.

Of the last four earnings reports from Alector Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.39 for the next earnings report. Alector Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Alector Inc. is Moderate Buy (1.72), with a target price of $20.75, which is +57.20% compared to the current price. The earnings rating for Alector Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Alector Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Alector Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 11.79, ATR14 : 0.74, CCI20 : 127.79, Chaikin Money Flow : 0.07, MACD : 0.63, Money Flow Index : 69.07, ROC : 19.57, RSI : 55.76, STOCH (14,3) : 91.50, STOCH RSI : 0.98, UO : 63.86, Williams %R : -8.50), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Alector Inc. in the last 12-months were: Arnon Rosenthal (Sold 589 625 shares of value $14 966 582 ), Robert King (Sold 714 shares of value $11 032 ), Shehnaaz Suliman (Option Excercise at a value of $2 584 500), Shehnaaz Suliman (Sold 150 000 shares of value $3 225 315 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (66.67 %)
6 (66.67 %)
4 (57.14 %)
Moderate Buy
1 (11.11 %)
1 (11.11 %)
1 (14.29 %)
Hold
1 (11.11 %)
1 (11.11 %)
1 (14.29 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (11.11 %)
1 (11.11 %)
1 (14.29 %)
Summary RatingModerate Buy
1.72
Moderate Buy
1.72
Moderate Buy
1.93

Alector Inc.

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain.

CEO: Arnon Rosenthal

Telephone: +1 415 231-5660

Address: 131 Oyster Point Boulevard, South San Francisco 94080, CA, US

Number of employees: 171

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

77%23%

Bearish Bullish

62%38%

TipRanks News for ALEC

Wed, 10 Aug 2022 03:50 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Masimo (MASI), Alector (ALEC) and Satsuma Pharmaceuticals (STSA)

- TipRanks. All rights reserved.

Tue, 24 May 2022 16:41 GMT Alector (ALEC) Receives a Sell from Goldman Sachs

- TipRanks. All rights reserved.

Sun, 27 Feb 2022 11:28 GMT Alector (ALEC) Receives a Buy from Citigroup

- TipRanks. All rights reserved.

News

Stocktwits